TITLE

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

AUTHOR(S)
Faries, Douglas; Ascher-Svanum, Haya; Baojin Zhu; Correll, Christoph; Kane, John
PUB. DATE
January 2005
SOURCE
BMC Psychiatry;2005, Vol. 5, p26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Antipsychotic monotherapy is recognized as the treatment of choice for patients with schizophrenia. Simultaneous treatment with multiple antipsychotics (polypharmacy) is suggested by some expert consensus guidelines as the last resort after exhausting monotherapy alternatives. This study assessed the annual rate and duration of antipsychotic monotherapy and its inverse, antipsychotic polypharmacy, among schizophrenia patients initiated on commonly used atypical antipsychotic medications. Methods: Data were drawn from a large prospective naturalistic study of patients treated for schizophrenia-spectrum disorders, conducted 7/1997-9/2003. Analyses focused on patients (N = 796) who were initiated during the study on olanzapine (N = 405), quetiapine (N = 115), or risperidone (N = 276). The percentage of patients with monotherapy on the index antipsychotic over the 1-year post initiation, and the cumulative number of days on monotherapy were calculated for all patients and for each of the 3 atypical antipsychotic treatment groups. Analyses employed repeated measures generalized linear models and non-parametric bootstrap re-sampling, controlling for patient characteristics. Results: During the 1-year period, only a third (35.7%) of the patients were treated predominately with monotherapy (>300 days). Most patients (57.7%) had at least one prolonged period of antipsychotic polypharmacy (>60 consecutive days). Patients averaged 195.5 days on monotherapy, 155.7 days on polypharmacy, and 13.9 days without antipsychotic therapy. Olanzapine-initiated patients were significantly more likely to be on monotherapy with the initiating antipsychotic during the 1-year post initiation compared to risperidone (p = .043) or quetiapine (p = .002). The number of monotherapy days was significantly greater for olanzapine than quetiapine (p < .001), but not for olanzapine versus risperidone, or for risperidone versus quetiapine-initiated patients. Conclusion: Despite guidelines recommending the use of polypharmacy only as a last resort, the use of antipsychotic polypharmacy for prolonged periods is very common during the treatment of schizophrenia patients in usual care settings. In addition, in this non-randomized naturalistic observational study, the most commonly used atypical antipsychotics significantly differed on the rate and duration of antipsychotic monotherapy. Reasons for and the impact of the predominant use of polypharmacy will require further study.
ACCESSION #
29323709

 

Related Articles

  • The lifetime outcome and involuntary movements of schizophrenia never treated with neuroleptic drugs. Four rare cases in Ireland. Waddington, John L.; Youssef, Hanafy A.; Waddington, J L; Youssef, H A // British Journal of Psychiatry;Jan90, Vol. 156, p106 

    Four elderly schizophrenic patients who had never been treated with neuroleptics, and a fifth patient who had received only the briefest exposure to such drugs, had retained their distinct clinical characteristics. Involuntary orofacial movements and cognitive dysfunction were found more...

  • The clinical correlates of neurological soft signs in chronic schizophrenia. King, D. J.; Wilson, A.; Cooper, S. J.; Waddington, J. L. // British Journal of Psychiatry;Jun91, Vol. 158, p770 

    Among 16 chronic schizophrenic in-patients, all had at least one neurological soft sign (NSS), and 6 (40%) had definite neurodysfunction. NSS and TD scores were highly intercorrelated, and NSS were significantly correlated with neuroleptic drug exposure. NSS correlated positively with both...

  • Plasma Omentin Levels in Drug-Free Patients with Schizophrenia. Yildirim, Osman; Canan, Fatih; Tosun, Mehmet; Kayka, Nefise; Tuman, Taha Can; alhan, Cafer; alcelik, aytekin // Neuropsychobiology;Jun2014, Vol. 69 Issue 3, p159 

    Aims: We aimed to investigate plasma omentin concentrations in non-obese, drug-free patients with schizophrenia in comparison with healthy volunteers. Method: Thirty-two patients with schizophrenia and 33 control subjects were recruited. Plasma omentin levels were determined by enzyme-linked...

  • A comparison of academic and lay theories of schizophrenia. Furnham, A.; Bower, P. // British Journal of Psychiatry;Aug92, Vol. 161, p201 

    This study investigated lay subjects' theories of schizophrenia. A questionnaire examining the five identified main academic theories of schizophrenia (medical, moral-behavioural, social, psychoanalytic, and conspiratorial) along various dimensions (aetiology, behaviour, treatment, function of...

  • A study of cranial computertomograms in very early and early onset schizophrenia. Badura, F.; Trott, G.-E.; Mehler-Wex, C.; Scheuerpflug, P.; Hofmann, E.; Warmuth-Metz, M.; Nadjmi, M.; Solymosi, L.; Warnke, A. // Journal of Neural Transmission;Nov2001, Vol. 108 Issue 11, p1335 

    Summary. The cranial computer-assisted tomograms of 19 patients suffering from schizophrenic psychoses with onset by age of 14 were examined. The emphasis was on the extent of the inner liquor spaces. Compared to healthy controls, at the beginning of illness a significant enlargement was...

  • Preschizophrenics: adding to the evidence, sharpening the focus. Ambelas, Aris; Ambelas, A // British Journal of Psychiatry;Mar92, Vol. 160, p401 

    The notion of a subclinical preschizophrenic condition already present in childhood is given further support by the findings of this follow-back study, which also brings into sharper focus the childhood profile of the likely adult schizophrenic.

  • Magnetic resonance imaging findings in schizophrenia and atypical psychoses. Hayashi, T.; Hotta, N.; Andoh, T.; Mori, M.; Fukatsu, N.; Suga, H. // Journal of Neural Transmission;Jun2001, Vol. 108 Issue 6, p695 

    Summary. The differences among MRI findings were studied in schizophrenic psychoses. The schizophrenics and atypical psychotics had significant reductions in bilateral hippocampal volumes compared to controls, but the two patient groups did not differ from each other. As for ventricle volume,...

  • Attitudes Towards Antipsychotics Among Patients with Schizophrenia on First- or Second-Generation Medications. Karthik, M. S.; Warikoo, Nisha; Chakrabarti, Subho; Grover, Sandeep; Kulhara, Parmanand // Indian Journal of Psychological Medicine;Jul-Sep2014, Vol. 36 Issue 3, p288 

    Background: Given the paucity of research in this area, this study attempted to assess attitudes toward antipsychotic medications and its correlates among patients with schizophrenia, either on first-generation antipsychotics (FGAs) or second-generation antipsychotics (SGAs) medications....

  • Labeling-stereotype-discrimination. Angermeyer, Matthias; Matschinger, Herbert // Social Psychiatry & Psychiatric Epidemiology;May2005, Vol. 40 Issue 5, p391 

    Aim Using Link and Phelan's concept of the stigma process, public attitudes towards people with schizophrenia are examined. Method In the spring of 2001, a representative population survey was conducted in Germany (n = 5025). A fully structured personal interview was carried out, beginning with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics